Biased neuromodulation lead and method of using same
A neuromodulation lead that is biased towards a substantially omega shape when fully deployed is provided. The neuromodulation lead includes a left set of electrodes disposed on a left portion of the lead body of the neuromodulation lead and a right set of electrodes disposed on a right portion of the lead body of the neuromodulation lead. The neuromodulation lead can be positioned in the plane between the genioglossus muscle and the geniohyoid muscle.
1 . A neuromodulation device comprising:
a power receiver; and
a neuromodulation lead comprising:
a lead body coupled to the power receiver, the lead body having a left portion, a right portion, and an intermediate portion connecting the left portion and the right portion,
a first plurality of electrodes disposed on the left portion of the lead body, and
a second plurality of electrodes disposed on the right portion of the lead body,
wherein the first plurality of electrodes and the second plurality of electrodes are configured to align with left nerve branches and right nerve branches of a hypoglossal nerve, respectively, when the neuromodulation device is implanted in a patient,
wherein the intermediate portion comprises a preformed shape such that when the lead body is placed between a geniohyoid muscle and a genioglossus muscle in the patient with the intermediate portion arranged inferior to the first plurality of electrodes and the second plurality of electrodes, the intermediate portion is configured to push the first plurality of electrodes and second plurality of electrodes further cranially into the genioglossus muscle, and
wherein the lead body has a proximal portion and a distal portion, the proximal portion of the lead body extending between the power receiver and the distal portion of the lead body, and the distal portion comprising the left and right portions, wherein the distal portion comprises a free distal end unattached to the power receiver.
2 . The neuromodulation device of claim 1 , wherein the lead body and power receiver are configured to be implanted at a submental region of a human patient.
3 . The neuromodulation device of claim 1 , wherein the proximal portion of the lead body is configured to fold over itself when the neuromodulation device is implanted.
4 . The neuromodulation device of claim 1 , further comprising an electronics package comprising electronics operably coupled to the power receiver and configured to control application of stimulation energy via one or more of the first and second plurality of electrodes, wherein the power receiver is configured to supply electrical current to the electronics to power the electronics.
5 . The neuromodulation device of claim 1 , wherein the power receiver comprises an antenna.
6 . The neuromodulation device of claim 1 , wherein the lead body is elongated.
7 . The neuromodulation device of claim 1 , wherein the lead body has a length and flexibility that allows the lead body to fold over itself when the neuromodulation device is implanted.
8 . The neuromodulation device of claim 1 , wherein the lead body is elongated and has a cylindrical or oval cross-sectional shape.
9 . The neuromodulation device of claim 1 , wherein the free distal end is unattached to another portion of the neuromodulation device.
10 . The neuromodulation device of claim 1 , wherein the proximal portion of the lead body has a length and flexibility such that the lead body is foldable to a configuration in which the distal portion of the lead body at least partially overlaps with the power receiver.
11 . The neuromodulation device of claim 1 , wherein the lead body has a single termination comprising the free distal end.
12 . A neuromodulation device comprising:
a power receiver;
an elongated lead body coupled to the power receiver, the lead body having a longitudinal dimension and a lateral dimension angled relative to the longitudinal dimension, the lead body comprising:
a first portion extending along the longitudinal dimension of the lead body from a first proximal end at the power receiver to a first distal end spaced apart from the power receiver by a first distance,
a second portion extending along the lateral dimension of the lead body from a second proximal end at the first distal end of the first portion to a second distal end, the second distal end spaced apart from the power receiver by a second distance greater than the first distance, and
a third portion extending along the longitudinal dimension from a third proximal end at the second distal end of the second portion to a third distal end, the third distal end spaced apart from the power receiver by a third distance greater than the second distance, wherein the third portion is laterally spaced apart from the first portion; and
at least one electrode carried by the lead body and configured to be positioned proximate either the left or right nerve branches of a hypoglossal nerve of a patient,
wherein the lead body comprises a free distal end unattached to the power receiver, and
wherein the lead body comprises a preformed bend between the second and third portions of the lead body such that when the lead body is placed between a geniohyoid muscle and a genioglossus muscle in the patient, the lead body is configured to push the at least one electrode further cranially into the genioglossus muscle.
13 . The neuromodulation device of claim 12 , wherein the third portion of the lead body is configured to be positioned in a plane between the geniohyoid muscle of the patient and the genioglossus muscle of the patient when the neuromodulation device is implanted in the patient.
14 . The neuromodulation device of claim 12 , wherein the at least one electrode is configured to be positioned on one or more fat pads located in a plane between the geniohyoid muscle of the patient and a genioglossus muscle of the patient when the neuromodulation device is implanted in the patient.
15 . The neuromodulation device of claim 12 , wherein the power receiver is configured to be positioned deep to a digastric muscle of the patient and on top of a mylohyoid muscle of the patient when the neuromodulation device is implanted in the patient.
16 . The neuromodulation device of claim 12 , wherein the power receiver comprises an antenna including a flexible circuit board and the neuromodulation device further comprises one or more electrical components configured to control an application of stimulation energy via the electrode, wherein the one or more electrical components are mounted on a portion of the flexible circuit board.
17 . The neuromodulation device of claim 12 , wherein the free distal end is unattached to another portion of the neuromodulation device.
18 . The neuromodulation device of claim 12 , wherein the lead body has a single termination comprising the free distal end.
19 . A neuromodulation device comprising:
a power receiver;
an elongated lead body coupled to the power receiver, the lead body having a longitudinal dimension and a lateral dimension angled relative to the longitudinal dimension, the lead body comprising:
a first portion extending along the longitudinal dimension of the lead body from a first proximal end at the power receiver to a first distal end spaced apart from the power receiver,
a second portion extending along the lateral dimension of the lead body from a second proximal end at the first distal end of the first portion to a second distal end, and
a third portion extending along the longitudinal dimension from a third proximal end at the second distal end of the second portion to a third distal end,
wherein the third portion is laterally spaced apart from and substantially parallel to the first portion, and
wherein the second portion is disposed at a first angle to the first portion and the second portion is disposed at a second angle to the third portion, the first angle and the second angle both being obtuse; and
at least one electrode carried by the lead body and configured to be positioned proximate either the left or right nerve branches of a hypoglossal nerve of a patient,
wherein the lead body comprises a free distal end unattached to the power receiver, and
wherein the lead body comprises a preformed bend between the second and third portions of the lead body such that when the lead body is placed between a geniohyoid muscle and a genioglossus muscle in the patient, the lead body is configured to push the at least one electrode further cranially into the genioglossus muscle.
20 . The neuromodulation device of claim 19 , wherein the first portion of the lead body is configured to fold over itself when the neuromodulation device is implanted in the patient.
21 . The neuromodulation device of claim 19 , wherein the at least one electrode is configured to be positioned between a geniohyoid muscle of the patient and a genioglossus muscle of the patient.
22 . The neuromodulation device of claim 19 , wherein the power receiver is configured to be positioned deep to a digastric muscle of the patient and on top of a mylohyoid muscle of the patient when the neuromodulation device is implanted in the patient.
23 . The neuromodulation device of claim 19 , wherein the elongated lead body comprises one or more tines configured to prevent or limit motion of the lead body when the neuromodulation device is implanted in the patient.
24 . The neuromodulation device of claim 19 , wherein the free distal end is unattached to another portion of the neuromodulation device.
25 . The neuromodulation device of claim 19 , wherein the lead body has a single termination comprising the free distal end.